Nanoviricides Inc (NNVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,207 | -4,563 | -2,531 | -1,140 | -6,477 |
| Depreciation Amortization | 220 | 165 | 110 | 55 | 528 |
| Accounts payable and accrued liabilities | 62 | 52 | 423 | 266 | -779 |
| Other Working Capital | 149 | 112 | 453 | 343 | -691 |
| Other Operating Activity | 1,559 | 914 | -357 | -200 | 2,912 |
| Operating Cash Flow | $-4,218 | $-3,321 | $-1,903 | $-676 | $-4,508 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -23 | -23 | -23 | -23 | -153 |
| Purchase Sale Intangibles | -35 | -35 | -24 | -6 | -41 |
| Other Investing Activity | -35 | -35 | -24 | -6 | -41 |
| Investing Cash Flow | $-59 | $-59 | $-47 | $-29 | $-194 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 9,328 | 7,140 | 4,825 | 2,361 | 6,970 |
| Financing Cash Flow | $9,328 | $7,140 | $4,825 | $2,361 | $6,970 |
| Beginning Cash Position | 9,224 | 9,224 | 9,224 | 9,224 | 6,956 |
| End Cash Position | 14,275 | 12,984 | 12,099 | 10,879 | 9,224 |
| Net Cash Flow | $5,051 | $3,760 | $2,875 | $1,655 | $2,268 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,218 | -3,321 | -1,903 | -676 | -4,508 |
| Capital Expenditure | -23 | -23 | -23 | -23 | -153 |
| Free Cash Flow | -4,241 | -3,345 | -1,926 | -700 | -4,661 |